The U.S. Food and Drug Administration (FDA) announced the launch of the Digital Health Center of Excellence.
The Center for Digital Health Excellence (DHCoE) center represents an important advancement within Digital Health and the promotion of the advancement of such technologies as medical software, portable devices with focuses on health, and other technologies for the study of medical products.
The FDA appointed Bakul Patel, who has been part of the FDA for more than 12 years and has stood out for his work at the agency to achieve regulatory and scientific frameworks related to Digital Health devices since 2010.
“Establishing the Digital Health Center of Excellence is part of the FDA’s work to ensure that the most cutting-edge digital health technologies are rapidly developed and reviewed in the U.S.,” said FDA Commissioner Stephen M. Hahn, M.D. According to the commissioner, DHCoE represents a new stage in the implementation of a comprehensive approach to Digital Health technologies and thus exploit their potential, and provide safety to consumers to make better informed decisions about their health. Digital Health offers options that facilitate the prevention and early diagnosis of diseases, as well as in the management and promotion of self-care for patients with chronic diseases.
DHCoE's main functions include supporting stakeholders, both external and external, in their goals of promoting high-quality health technologies, as well as promoting best practices within Digital Health. Despite being a fully developed project, DHCoE is an agency that has committed to advancing science and evidence for new Digital Health technologies, complying with regulatory frameworks involved by the FDA.
Their first actions have been to create a network of experts and form different collaborative communities for the exchange of knowledge and experiences, for this they have included the launch of strategic initiatives that promote technologies in Digital Health.
